SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Oyster Point Pharma, Inc. Buyout

November 21, 2022 10:21 AM EST | Source: Rigrodsky Law, P.A.

Wilmington, Delaware--(Newsfile Corp. - November 21, 2022) - Rigrodsky Law, P.A. is investigating Oyster Point Pharma, Inc. ("Oyster") (NASDAQ: OYST) regarding possible breaches of fiduciary duties and other violations of law related to Oyster's agreement to be acquired by Viatris Inc. Under the terms of the agreement, Oyster's shareholders will receive $11.00 per share and a contingent value right for a potential cash payment of up to $2.00 per share.

To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-oyster-point-pharma-inc.

To contact Seth D. Rigrodsky or Gina M. Serra cost free, call or text (302) 295-5310 or email info@rl-legal.com.

Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

Contact:
Rigrodsky Law, P.A.
Seth D. Rigrodsky, Esq.
Gina M. Serra, Esq.
Call or Text: (302) 295-5310
Email: info@rl-legal.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/145067

info